Motoneuronal mechanisms underlying age-related muscle weakness
年龄相关性肌肉无力的运动神经机制
基本信息
- 批准号:10641197
- 负责人:
- 金额:$ 23.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:Action PotentialsAgeAge-MonthsAgingAnimalsCalcium-Activated Potassium ChannelCell membraneClinicalCommunitiesCross-Sectional StudiesDataDevelopmentDiseaseElderlyExhibitsExtensorFunctional disorderGoalsHumanImmunohistochemistryImpairmentIn SituIn VitroIncidenceInterventionIon ChannelKnowledgeLeadLegMeasuresMembraneMissionMolecularMotorMotor NeuronsMusMuscleMuscle FibersMuscle functionMuscular AtrophyNational Institute on AgingNeurologicPhysiologicalPlayPreparationPublic HealthResearchResearch DesignRisk FactorsRoleSensorySeriesSpinal CordTestingTimeTimeLineUnited States National Institutes of HealthUp-RegulationWestern BlottingWorkage relatedage-related muscle weaknessagedbasebiomarker developmentcohortearly detection biomarkersexperienceexperimental studyfrailtyhuman datahuman old age (65+)in vivomuscle formmuscle strengthneuromechanismphysically handicappedpreventprotein expressionsarcopeniasex
项目摘要
ABSTRACT
Forty-two percent of older adults have one or more physical limitations performing daily tasks that are essential
for maintaining independence in the community. Age-related weakness is an important contributor to physical
impairments, as weakness predisposes older adults to a 4-fold increase in physical limitations. For decades,
age-related weakness was largely attributed to the loss of muscle mass, but recent data indicates that mass
plays a lesser role than originally thought, highlighting that other neurological and/or muscle quality related
factors are critical in the development of weakness. Despite the significance of maintaining physical strength in
aging, the majority of the research has focused on maintaining muscle mass. Considerably less is known
regarding the neural mechanisms potentially contributing to age-related weakness. This knowledge gap
represents a barrier to the development of new interventions to enhance strength and function in older adults.
In this application we will test the central hypothesis that age-related weakness is due, in part, to upregulation in
motor neuron (MN) SK channels (small conductance calcium-activated potassium channels) that results in type-
dependent reductions in intrinsic MN excitability and firing rates. Prior work indicates that aging results in reduced
number of MUs (the α-MN and the muscle fibers that it innervates) and lower firing rates. However, prior work
has stopped short of determining whether age-related reductions in MU numbers are related to clinically-
meaningful weakness, and determining the ionic mechanisms underlying reduced MN firing rates in aging. In
this application we propose a series of parallel, cross-sectional and longitudinal animal (Aims 1 and 2) and
human experiments (Aim 3) to test our central hypothesis. Aim 1 will determine if MN excitability dysfunction is
involved in age-related weakness and determine its temporal relationship to MU loss in mice. Aim 2 will identify
the cellular mechanisms underlying MN excitability dysfunction in aged mice. Aim 3 will determine the role of MN
excitability and number in clinically-meaningful, age-related weakness in older adults. This work aligns with
stated goals from the National Institute on Aging (NIA). The knowledge to be gained from this work has the
potential to fundamentally shift the fields of sarcopenia and frailty research towards MN excitability as an early
biomarker for the development of weakness, and identifying key MN ion channels that could serve as a
neurotherapeutic targets for treating or preventing age-related weakness.
抽象的
42%的老年人有一个或多个身体限制,执行日常任务,这是必不可少的
保持社区独立。与年龄有关的弱点是身体的重要贡献
障碍,因为弱点使老年人的身体局限性增加了4倍。几十年来,
与年龄有关的弱点主要归因于肌肉质量的损失,但最近的数据表明质量
扮演的角色比最初想象的要少,强调了其他神经和/或肌肉质量相关的角色
因素对于弱点的发展至关重要。尽管保持体力
衰老,大多数研究都集中于维持肌肉质量。少得多
关于神经机制可能导致与年龄有关的弱点。这个知识差距
代表了开发新干预措施以增强老年人力量和功能的障碍。
在此应用中,我们将测试中心假设,即与年龄相关的弱点部分是由于上调
运动神经元(MN)SK通道(小电导钙激活的钾通道),导致类型
固有的MN兴奋性和发射速率的依赖性降低。先前的工作表明衰老导致减少
MUS的数量(α-MN和其支配的肌肉纤维)和降低速率。但是,先前的工作
缺乏确定与年龄相关的MU数量的减少是否与临床上的相关
有意义的弱点,并确定衰老中Mn发射率降低的离子机制。在
我们提出了一系列平行,横截面和纵向动物(目标1和2),以及
人类实验(目标3)以检验我们的中心假设。 AIM 1将确定MN兴奋性功能障碍是否为
涉及与年龄相关的弱点,并确定其与小鼠中MU损失的暂时关系。 AIM 2将确定
老年小鼠中MN兴奋性功能障碍的细胞机制。 AIM 3将决定MN的作用
老年人的兴奋性和临床上与年龄相关的弱点的兴奋性和数量。这项工作与
陈述了美国国家老化研究所(NIA)的目标。从这项工作中获得的知识具有
从根本上将肌肉减少症和脆弱研究的领域转变为MN令人兴奋的潜力
生物标志物用于发展弱点,并确定可以用作的关键MN离子渠道
用于治疗或预防与年龄相关的弱点的神经治疗靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William David Arnold其他文献
William David Arnold的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William David Arnold', 18)}}的其他基金
Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography
通过电阻抗肌电图准确快速评估老年人肌少症
- 批准号:
10484558 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别:
Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography
通过电阻抗肌电图准确快速评估老年人肌少症
- 批准号:
10668482 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别:
Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography - Development of Regulatory Plans Supplement
通过电阻抗肌动描记法准确、快速地评估老年人的肌少症 - 制定监管计划补充材料
- 批准号:
10700526 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别:
Motoneuronal mechanisms underlying age-related muscle weakness
年龄相关性肌肉无力的运动神经机制
- 批准号:
10810941 - 财政年份:2021
- 资助金额:
$ 23.49万 - 项目类别:
Motoneuronal mechanisms underlying age-related muscle weakness
年龄相关性肌肉无力的运动神经机制
- 批准号:
10407020 - 财政年份:2021
- 资助金额:
$ 23.49万 - 项目类别:
Motoneuronal mechanisms underlying age-related muscle weakness
年龄相关性肌肉无力的运动神经机制
- 批准号:
10612078 - 财政年份:2021
- 资助金额:
$ 23.49万 - 项目类别:
Motoneuronal mechanisms underlying age-related muscle weakness
年龄相关性肌肉无力的运动神经机制
- 批准号:
10618019 - 财政年份:2021
- 资助金额:
$ 23.49万 - 项目类别:
Motoneuronal mechanisms underlying age-related muscle weakness
年龄相关性肌肉无力的运动神经机制
- 批准号:
10543345 - 财政年份:2021
- 资助金额:
$ 23.49万 - 项目类别:
Social Isolation and Loss of Physical Function: Defining a Novel Neuromuscular Phenotype
社会孤立和身体功能丧失:定义一种新的神经肌肉表型
- 批准号:
10057744 - 财政年份:2020
- 资助金额:
$ 23.49万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Voltage Imaging of Astrocyte-Neuron Interactions
星形胶质细胞-神经元相互作用的电压成像
- 批准号:
10711423 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
Multimodal ventral tegmental area decrements in a mouse Alzheimer's model
小鼠阿尔茨海默病模型中多模式腹侧被盖面积减少
- 批准号:
10537306 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别:
Impact of Schwann Cell Pathology on Axon Structure and Function
雪旺细胞病理学对轴突结构和功能的影响
- 批准号:
10568051 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别:
Rescuing neurovascular coupling to protect neuronal plasticity and cognition
拯救神经血管耦合以保护神经元可塑性和认知
- 批准号:
10530887 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别:
Multimodal ventral tegmental area decrements in a mouse Alzheimer's model
小鼠阿尔茨海默病模型中多模式腹侧被盖面积减少
- 批准号:
10709503 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别: